Research Peptides Canada — Lyophilized Vials, Tested Per Lot

Peptides

Retatrutide 10 mg

Triple GIP / GLP-1 / Glucagon Agonist · 10, 20, 40 & 120 mg Retatrutide is a synthetic peptide developed for controlled laboratory research involving multi-receptor signaling systems. It is structurally designed to interact with GLP-1, GIP, and glucagon receptor pathways within experimental environments.

RETA-CA-26F-1099.637%

11.76 mg / 10 mg

Peptides

Tirzepatide 10 mg

Dual GIP / GLP-1 Agonist · 10, 30 & 65 mg Tirzepatide is a synthetic peptide developed for controlled laboratory research involving dual incretin receptor signaling systems. It is structurally designed to interact with GLP-1 and GIP receptor pathways within experimental environments.

TIRZ-CA-26G-1099.634%

11.42 mg / 10 mg

Peptides

Semaglutide 10 mg

GLP-1 Receptor Agonist · 10 mg Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in glucose-dependent signaling. It is developed for controlled laboratory investigation within regulated experimental environments.

SEMA-CA-26F-1099.504%

11.27 mg / 10 mg

Peptides

Eloralintide 10 mg

Selective Amylin Agonist (LY3841136) · 10 mg This product is supplied as eloralintide (LY3841136), a long-acting, selective amylin receptor agonist studied in research on metabolic and body-weight regulation.

ELOR-CA-26G-1099.810%

12.42 mg / 10 mg

Peptides

Cagrilintide 5 mg

Long-Acting Amylin Analogue · 5 & 10 mg Cagrilintide is a synthetic peptide developed for controlled laboratory research involving amylin receptor signaling systems. It is structurally designed to interact with amylin-associated pathways within experimental environments.

CAG-CA-26A-0199.446%

5.62 mg / 5 mg

Peptides

BPC-157 10 mg

Body Protection Compound Pentadecapeptide · 10 mg BPC-157 is a synthetic peptide derived from a fragment of a naturally occurring gastric protein. It is produced for laboratory research and studied within controlled experimental environments.

BPC-CA-26F-1099.765%

10.98 mg / 10 mg

Peptides

TB-500 10 mg

Thymosin Beta-4 Fragment Research Peptide TB-500 is a synthetic research peptide modeled after thymosin beta-4, a naturally occurring peptide involved in cellular signaling processes. It is developed for controlled laboratory investigation within regulated experimental environments.

TB5-CA-26F-1099.182%

11.52 mg / 10 mg

Peptides

KPV 10 mg

Tripeptide Research Compound KPV is a synthetic tripeptide composed of lysine–proline–valine and represents a fragment derived from the alpha-melanocyte–stimulating hormone (α-MSH) sequence. It is developed for controlled laboratory research involving peptide-mediated signaling systems.

KPV-CA-26F-1099.023%

12.05 mg / 10 mg

Peptides

Wolverine Stack 10 mg

Multi-Peptide Research Blend Wolverine Stack, the BPC-157 – TB-500 blend, is a dual-peptide research formulation combining BPC-157 and TB-500 in equal concentrations.

BPCT-CA-26F-01

BPC-157 6.25 mg / TB-500 (TB4) 5.86 mg / 10 mg

Peptides

Deadpool Blend 20 mg

Recovery Blend Deadpool is a research blend supplying cartalax, BPC-157, and TB-500 in a single vial.

CTBT-CA-26F-20

Cartalax 10.72 mg / BPC-157 5.98 mg / TB-500 (TB4) 5.75 mg / 20 mg

Peptides

Coremend Blend 45 mg

TB-500 / BPC-157 / KPV Recovery Blend Coremend is a research blend combining TB-500 (thymosin beta-4 fragment), BPC-157, and the tripeptide KPV in a single preparation, studied for converging tissue-repair and inflammatory-signaling pathways.

CORE-CA-26H-45

KPV 11.30 mg / BPC-157 11.85 mg / TB-500 (TB4) 26.93 mg / 45 mg

Peptides

KLOW Blend 80 mg

Multi-Peptide Research Blend KLOW is a multi-peptide research blend integrating GHK-Cu, BPC-157, TB-500, and KPV into a unified formulation developed for controlled laboratory investigation.

KLOW-CA-26G-01

GHK-Cu 63.68 mg / TB-500 (TB4) 11.30 mg / BPC-157 12.11 mg / KPV 10.92 mg / 80 mg

Peptides

GLOW Blend 70 mg

Multi-Peptide Research Blend GLOW is a multi-peptide research blend formulated for controlled laboratory investigation. It integrates GHK-Cu, BPC-157, and TB-500 into a single experimental compound.

GLOW-CA-26F-70

GHK-Cu 63.75 mg / TB-500 (TB4) 11.64 mg / BPC-157 12.16 mg / 70 mg

Peptides

MOTS-c 10 mg

Mitochondrial-Derived Peptide MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondrial-derived peptide identified through genomic analysis of mitochondrial DNA. It is synthesized for controlled laboratory research and studied within experimental environments focused on cellular and metabolic signaling.

MOTS-CA-26F-1099.34%

12.65 mg / 10 mg

Peptides

SS-31 50 mg

Mitochondria-Targeted Peptide Research Compound SS-31 is a synthetic tetrapeptide designed for controlled laboratory research involving mitochondrial-associated signaling systems. It is also known in scientific literature as elamipretide.

SS31-CA-26F-5099.768%

50.86 mg / 50 mg

Peptides

5-Amino-1MQ 10 mg

Nicotinamide N-Methyltransferase (NNMT) Inhibitor Research Compound 5-Amino-1MQ is a small-molecule research compound studied as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolic regulation. It is developed for controlled laboratory investigation within experimental environments.

51Q-CA-26A-0199.55%

11.17 mg / 10 mg

Peptides

Mito-Genesis Blend 120 mg

Mitochondrial Blend Mito-Genesis is a research blend supplying NAD+, 5-Amino-1MQ, and MOTS-c in a single vial.

MITO-CA-26F-120

NAD+ 99.22 mg / MOTS-c 11.43 mg / 5-Amino-1MQ 11.14 mg / 120 mg

Peptides

Tesamorelin 10 mg

GHRH Analogue Research Peptide Tesamorelin is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH). It is developed for controlled laboratory research involving hypothalamic-pituitary signaling systems.

TESA-CA-26F-1098.763%

11.68 mg / 10 mg

Peptides

Tesamorelin / Ipamorelin Blend 13 mg

Tesamorelin / Ipamorelin GH-Axis Blend The Tesamorelin + Ipamorelin blend combines a GHRH analogue (Tesamorelin) with a selective ghrelin-receptor agonist (Ipamorelin), studied for complementary stimulation of the GH/IGF-1 axis.

TIPA-CA-26G-13

Tesamorelin 10.87 mg / Ipamorelin 3.53 mg / 13 mg

Peptides

Triad-GH Blend 12 mg

Growth Hormone Secretagogue Blend Triad-GH is a research blend supplying tesamorelin, ipamorelin, and CJC-1295 (No DAC) in a single vial.

TICA-CA-26G-12

Tesamorelin 6.74 mg / Ipamorelin 3.61 mg / CJC-1295 (mod GRF 1-29) 3.76 mg / 12 mg

Peptides

CJC-1295 / Ipamorelin Blend 10 mg

Dual GHRH / GHS-R Research Blend CJC-1295 + Ipamorelin is a dual-peptide research formulation combining a growth hormone–releasing hormone (GHRH) analogue with a selective ghrelin receptor (GHS-R1a) agonist. It is developed for controlled laboratory investigation involving hypothalamic-pituitary signaling systems.

CJIP-CA-26F-10

CJC-1295 (mod GRF 1-29) 5.57 mg / Ipamorelin 5.88 mg / 10 mg

Peptides

CJC-1295 (No DAC) 10 mg

GHRH Analogue Research Peptide CJC-1295 (No DAC) is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH) developed for controlled laboratory research. The “No DAC” designation indicates the absence of a drug affinity complex, resulting in a shorter receptor interaction profile within experimental systems.

CJND-CA-26F-1099.777%

10.76 mg / 10 mg

Peptides

Ipamorelin 10 mg

Ghrelin Receptor Research Peptide Ipamorelin is a synthetic peptide developed for controlled laboratory research involving ghrelin receptor signaling systems. It is structurally designed to interact with growth hormone secretagogue receptor (GHS-R1a) pathways within experimental environments.

IPAM-CA-26G-1099.753%

11.75 mg / 10 mg

Peptides

IGF-1 LR3 1 mg

Long-Acting IGF-1 Analogue IGF-1 LR3 is a synthetic analogue of insulin-like growth factor 1 (IGF-1) modified with an extended amino acid sequence to alter receptor interaction characteristics. It is developed for controlled laboratory research involving IGF-1 receptor signaling systems.

IGF1-CA-26A-0198.587%

1.12 mg / 1 mg

Peptides

AOD-9604 5 mg

Growth Hormone Fragment AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment (176–191) of human growth hormone, studied in research for lipolytic-pathway activity.

AOD-CA-26F-05

Peptides

Selank 10 mg

Synthetic Heptapeptide Research Compound Selank is a synthetic heptapeptide derived from the endogenous tetrapeptide tuftsin with structural modifications for enhanced stability in experimental systems. It is developed for controlled laboratory research involving neuropeptide signaling pathways.

SLNK-CA-26F-1099.161%

10.55 mg / 10 mg

Peptides

N-Acetyl Selank 10 mg

Tuftsin-Analogue Anxiolytic Peptide N-Acetyl Selank is an N-acetylated form of Selank, a synthetic heptapeptide analogue of the immunomodulatory peptide tuftsin, studied in research for anxiolytic and neuromodulatory signaling.

NSLK-CA-26G-1099.712%

11.88 mg / 10 mg

Peptides

Semax 10 mg

ACTH-Derived Research Peptide Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4–10) with structural modification to enhance stability in experimental systems. It is developed for controlled laboratory research involving neuropeptide signaling pathways.

SMAX-CA-26G-1099.0.53%

10.69 mg / 10 mg

Peptides

N-Acetyl Semax 10 mg

ACTH(4-10)-Analogue Nootropic Peptide N-Acetyl Semax is an N-acetylated form of Semax, a synthetic analogue of an ACTH(4-10) fragment, studied in research for nootropic and neuroprotective signaling.

NASA-CA-26F-1099.303%

11.58 mg / 10 mg

Peptides

PT-141 10 mg

Melanocortin Receptor Research Peptide PT-141, also known as bremelanotide in scientific literature, is a synthetic peptide analogue derived from melanocortin receptor research. It is developed for controlled laboratory investigation involving melanocortin receptor signaling systems.

PT-CA-26A-0199.864%

11.86 mg / 10 mg

Peptides

Kisspeptin-10 10 mg

KISS1 Receptor Research Peptide Kisspeptin-10 is a synthetic decapeptide derived from the larger KISS1 peptide sequence. It is developed for controlled laboratory research involving KISS1 receptor (GPR54) signaling systems.

KSPN-CA-26G-1099.824%

13.21 mg / 10 mg

Peptides

Melanotan II 10 mg

Melanocortin Receptor Research Peptide Melanotan II is a synthetic cyclic peptide analogue derived from alpha-melanocyte–stimulating hormone (α-MSH). It is developed for controlled laboratory research involving melanocortin receptor signaling systems.

MT2-CA-26F-1099.887%

11.12 mg / 10 mg

Peptides

Melanotan-1 10 mg

Melanocortin Receptor Agonist Melanotan-1 (afamelanotide) is a synthetic analogue of α-melanocyte-stimulating hormone, studied in research for melanocortin-receptor signaling.

MT1-CA-26F-1099.794%

10.60 mg / 10 mg

Peptides

Thymosin Alpha-1 10 mg

Thymic Peptide Research Compound Thymosin Alpha-1 is a synthetic peptide analogue of a naturally occurring thymic hormone involved in immune signaling research. It is developed for controlled laboratory investigation within experimental environments.

TA1-CA-26F-1099.699%

11.64 mg / 10 mg

Peptides

P21 10 mg

Neurotrophic Peptide Mimetic P21 is a small peptidergic compound derived from an active region of ciliary neurotrophic factor (CNTF), studied in research for neurogenic and synaptogenic signaling.

P21-CA-26H-1099.339%

12.24 mg / 10 mg

Peptides

PE-22-28 10 mg

TREK-1 Channel Blocker PE 22-28 is a seven-residue peptide derived from spadin, itself a fragment of the sortilin (NTSR3) propeptide, studied in research as a blocker of the TREK-1 potassium channel.

PE22-CA-26F-0199.754%

12.86 mg / 10 mg

Peptides

Sermorelin 5 mg

GHRH(1-29) Analogue Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of growth-hormone-releasing hormone, studied in research on the GH/IGF-1 axis.

SERM-CA-26D-0198.78%

5.56 mg / 5 mg

Peptides

Oxytocin 10 mg

Neurohypophysial Nonapeptide Oxytocin is a nine–amino acid neuropeptide studied in research for its roles in neuroendocrine signaling and social behavior.

Ovagen

Peptides

ARA-290 20 mg

Non-Erythropoietic EPO Analogue ARA-290 (cibinetide) is a synthetic 11–amino acid peptide engineered from the structure of erythropoietin, studied in research for tissue-protective signaling without erythropoietic activity.

ARA2-CA-26G-1699.683%

19.28 mg / 20 mg

Peptides

HGH (Somatropin) 110 IU

Recombinant Growth Hormone HGH, also known as recombinant human growth hormone (somatropin), is a synthetic peptide hormone identical in sequence to endogenous human growth hormone. It is produced using recombinant DNA technology for controlled laboratory research.

HGH-CA-26G-10097.945%

3.86 mg / 11.58 IU / 110 IU

Peptides

DSIP 10 mg

Delta Sleep–Inducing Peptide DSIP, also known as Delta Sleep–Inducing Peptide, is a synthetic neuropeptide developed for controlled laboratory research. It was originally identified during investigations into sleep-phase regulation and neuroendocrine signaling systems.

DSIP-CA-26F-1099.623%

11.85 mg / 10 mg

Peptides

VIP 10 mg

Vasoactive Intestinal Peptide VIP is a 28–amino acid neuropeptide studied in research for vasodilatory, neuroendocrine, and immunomodulatory signaling.

Peptides

HCG

Gonadotropin Glycoprotein Human chorionic gonadotropin (hCG) is a glycoprotein hormone studied in research for its luteinizing-hormone-like activity and endocrine–immune signaling.

Peptides

CJC-1295 (With DAC) 5 mg

Long-Acting GHRH Analogue CJC-1295 with DAC is a synthetic analogue of growth-hormone-releasing hormone (GHRH 1-29) bearing a Drug Affinity Complex that extends its half-life, studied in research on the GH/IGF-1 axis.

Peptides

Mazdutide 10 mg

GLP-1 / Glucagon Dual Agonist · 10 mg Mazdutide is a synthetic peptide studied in research as a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucagon receptors.